Home
/
Beta Bionics, Inc.
/
Financials
/
Quarterly
Beta Bionics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Beta Bionics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$27.25M
Oct 28, 2025
Q2
2025
Jun 30, 2025
$23.24M
Jul 29, 2025
Q1
2025
Mar 31, 2025
$17.64M
May 6, 2025
Q3
2025
Sep 30, 2024
$16.71M
Oct 28, 2025
Q2
2025
Jun 30, 2024
$15.05M
Jul 29, 2025
Q1
2025
Mar 31, 2024
$12.93M
May 6, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($14.21M)
Oct 28, 2025
Q2
2025
Jun 30, 2025
($16.87M)
Jul 29, 2025
Q1
2025
Mar 31, 2025
($28.66M)
May 6, 2025
Q3
2025
Sep 30, 2024
($9.74M)
Oct 28, 2025
Q2
2025
Jun 30, 2024
($14.46M)
Jul 29, 2025
Q1
2025
Mar 31, 2024
($12.45M)
May 6, 2025
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($17.04M)
Oct 28, 2025
Q2
2025
Jun 30, 2025
($19.87M)
Jul 29, 2025
Q1
2025
Mar 31, 2025
($18.64M)
May 6, 2025
Q3
2025
Sep 30, 2024
($10.98M)
Oct 28, 2025
Q2
2025
Jun 30, 2024
($11.78M)
Jul 29, 2025
Q1
2025
Mar 31, 2024
($9.45M)
May 6, 2025